BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 27871280)

  • 1. Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design.
    van der Velden JM; Verkooijen HM; Seravalli E; Hes J; Gerlich AS; Kasperts N; Eppinga WS; Verlaan JJ; van Vulpen M
    BMC Cancer; 2016 Nov; 16(1):909. PubMed ID: 27871280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial.
    Braam P; Lambin P; Bussink J
    Trials; 2016 Feb; 17():61. PubMed ID: 26829933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design.
    Huele EH; van der Velden JM; Kasperts N; Eppinga WSC; Grutters JPC; Suelmann BBM; Weening AA; Delawi D; Teunissen SCCM; Verkooijen HM; Verlaan JJ; Gal R
    Trials; 2023 May; 24(1):307. PubMed ID: 37143158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
    Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
    Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
    BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
    Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial.
    Rief H; Katayama S; Bruckner T; Rieken S; Bostel T; Förster R; Schlampp I; Wolf R; Debus J; Sterzing F
    Trials; 2015 Jun; 16():264. PubMed ID: 26054533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial.
    Burbach JP; Verkooijen HM; Intven M; Kleijnen JP; Bosman ME; Raaymakers BW; van Grevenstein WM; Koopman M; Seravalli E; van Asselen B; Reerink O
    Trials; 2015 Feb; 16():58. PubMed ID: 25888548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced toxicity after image-guided and intensity-modulated radiotherapy versus external beam radiotherapy for patients with spinal bone metastases (IRON-1): a study protocol for a randomized controlled pilot trial.
    Meyerhof E; Sprave T; Welte SE; Nicolay NH; Förster R; Bostel T; Bruckner T; Schlampp I; Debus J; Rief H
    Trials; 2017 Mar; 18(1):98. PubMed ID: 28253920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).
    Mercier C; Dirix P; Ost P; Billiet C; Joye I; Vermeulen P; Lievens Y; Verellen D
    BMC Cancer; 2019 Sep; 19(1):876. PubMed ID: 31484505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
    Cellini F; Manfrida S; Deodato F; Cilla S; Maranzano E; Pergolizzi S; Arcidiacono F; Di Franco R; Pastore F; Muto M; Borzillo V; Donati CM; Siepe G; Parisi S; Salatino A; D'Agostino A; Montesi G; Santacaterina A; Fusco V; Santarelli M; Gambacorta MA; Corvò R; Morganti AG; Masiello V; Muto P; Valentini V
    Trials; 2019 Oct; 20(1):609. PubMed ID: 31661034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - a randomized phase III study.
    Bludau F; Welzel G; Reis T; Abo-Madyan Y; Sperk E; Schneider F; Clausen S; Ruder AM; Obertacke U; Ghaly MM; Wenz F; Giordano FA
    BMC Cancer; 2019 May; 19(1):430. PubMed ID: 31072314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.
    Rothrock RJ; Ozair A; Avendano MC; Herrera S; Appel H; Ramos S; Starosciak AK; Leon-Ariza DS; Rubens M; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha RR
    Trials; 2024 Jan; 25(1):41. PubMed ID: 38217032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial.
    Guckenberger M; Hawkins M; Flentje M; Sweeney RA
    BMC Cancer; 2012 Nov; 12():530. PubMed ID: 23164174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases.
    Ito K; Furuya T; Shikama N; Nihei K; Tanaka H; Kumazaki Y; Nishimura H; Karasawa K
    Jpn J Clin Oncol; 2019 Dec; 49(11):999-1003. PubMed ID: 31665478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).
    Mercier C; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Debois H; Huget P; Verellen D
    Radiat Oncol; 2018 Aug; 13(1):152. PubMed ID: 30126440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
    Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.